{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Notch signaling", "cancer stem cells", "cancer treatment", "\u03b3-secretase", "\u03b3-secretase inhibitors"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33673088", "DateCompleted": {"Year": "2021", "Month": "04", "Day": "08"}, "DateRevised": {"Year": "2021", "Month": "04", "Day": "08"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "02", "Day": "12"}], "Language": ["eng"], "ELocationID": ["972", "10.3390/molecules26040972"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "26", "Issue": "4", "PubDate": {"Year": "2021", "Month": "Feb", "Day": "12"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Unlocking the Secrets of Cancer Stem Cells with \u03b3-Secretase Inhibitors: A Novel Anticancer Strategy.", "Abstract": {"AbstractText": ["The dysregulation of Notch signaling is associated with a wide variety of different human cancers. Notch signaling activation mostly relies on the activity of the \u03b3-secretase enzyme that cleaves the Notch receptors and releases the active intracellular domain. It is well-documented that \u03b3-secretase inhibitors (GSIs) block the Notch activity, mainly by inhibiting the oncogenic activity of this pathway. To date, several GSIs have been introduced clinically for the treatment of various diseases, such as Alzheimer's disease and various cancers, and their impacts on Notch inhibition have been found to be promising. Therefore, GSIs are of great interest for cancer therapy. The objective of this review is to provide a systematic review of in vitro and in vivo studies for investigating the effect of GSIs on various cancer stem cells (CSCs), mainly by modulation of the Notch signaling pathway. Various scholarly electronic databases were searched and relevant studies published in the English language were collected up to February 2020. Herein, we conclude that GSIs can be potential candidates for CSC-targeting therapy. The outcome of our study also indicates that GSIs in combination with anticancer drugs have a greater inhibitory effect on CSCs."]}, "AuthorList": [{"Identifier": ["0000-0002-6190-0729"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Technology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah 6734667149, Iran."}, {"Identifier": [], "Affiliation": "Department of Biology, Faculty of Science, University of Guilan, Rasht 4193833697, Iran."}], "LastName": "Ghanbari-Movahed", "ForeName": "Maryam", "Initials": "M"}, {"Identifier": ["0000-0003-3353-7034"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Biology Research Center, Kermanshah University of Medical sciences, Kermanshah 6714415185, Iran."}], "LastName": "Ghanbari-Movahed", "ForeName": "Zahra", "Initials": "Z"}, {"Identifier": ["0000-0003-3957-3300"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Research Center, Institute of Medicinal Plants, Academic Center for Education, Culture and Research, Tehran 1417614411, Iran."}, {"Identifier": [], "Affiliation": "Toxicology and Diseases Group, The Institute of Pharmaceutical Sciences, Tehran University of Medical Sciences, Tehran 1417614411, Iran."}, {"Identifier": [], "Affiliation": "Gastrointestinal Pharmacology Interest Group, Universal Scientific Education and Research Network, Tehran 1417614411, Iran."}], "LastName": "Momtaz", "ForeName": "Saeideh", "Initials": "S"}, {"Identifier": ["0000-0001-9483-4652"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Lake Erie College of Osteopathic Medicine, Bradenton, FL 34211, USA."}], "LastName": "Kilpatrick", "ForeName": "Kaitlyn L", "Initials": "KL"}, {"Identifier": ["0000-0001-7081-6521"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medical Technology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah 6734667149, Iran."}], "LastName": "Farzaei", "ForeName": "Mohammad Hosein", "Initials": "MH"}, {"Identifier": ["0000-0001-9159-960X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Lake Erie College of Osteopathic Medicine, Bradenton, FL 34211, USA."}], "LastName": "Bishayee", "ForeName": "Anupam", "Initials": "A"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Enzyme Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Notch"}, {"RegistryNumber": "EC 3.4.-", "NameOfSubstance": "Amyloid Precursor Protein Secretases"}], "MeshHeadingList": [{"QualifierName": ["antagonists & inhibitors", "genetics"], "DescriptorName": "Amyloid Precursor Protein Secretases"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Enzyme Inhibitors"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": ["drug effects", "pathology"], "DescriptorName": "Neoplastic Stem Cells"}, {"QualifierName": ["antagonists & inhibitors", "genetics"], "DescriptorName": "Receptors, Notch"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ayob A.Z., Ramasamy T.S. Cancer stem cells as key drivers of tumour progression. J. Biomed. Sci. 2018;25:1\u201318.", "ArticleIdList": ["PMC5838954", "29506506"]}, {"Citation": "Lathia J.D., Liu H. Overview of cancer stem cells and stemness for community oncologists. Target. Oncol. 2017;12:387\u2013399. doi: 10.1007/s11523-017-0508-3.", "ArticleIdList": ["10.1007/s11523-017-0508-3", "PMC5524873", "28664387"]}, {"Citation": "Akbarzadeh M., Maroufi N.F., Tazehkand A.P., Akbarzadeh M., Bastani S., Safdari R., Farzane A., Fattahi A., Nejabati H.R., Nouri M. Current approaches in identification and isolation of cancer stem cells. J. Cell. Physiol. 2019;234:14759\u201314772. doi: 10.1002/jcp.28271.", "ArticleIdList": ["10.1002/jcp.28271", "30741412"]}, {"Citation": "Kemper K., Sprick M.R., de Bree M., Scopelliti A., Vermeulen L., Hoek M., Zeilstra J., Pals S.T., Mehmet H., Stassi G. The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation. Cancer Res. 2010;70:719\u2013729. doi: 10.1158/0008-5472.CAN-09-1820.", "ArticleIdList": ["10.1158/0008-5472.CAN-09-1820", "20068153"]}, {"Citation": "Weiswald L.-B., Bellet D., Dangles-Marie V. Spherical cancer models in tumor biology. Neoplasia. 2015;17:1\u201315.", "ArticleIdList": ["PMC4309685", "25622895"]}, {"Citation": "Liu J., Sato C., Cerletti M., Wagers A. Notch signaling in the regulation of stem cell self-renewal and differentiation. Curr. Top. Dev. Biol. 2010;92:367\u2013409.", "ArticleIdList": ["20816402"]}, {"Citation": "Venkatesh V., Nataraj R., Thangaraj G.S., Karthikeyan M., Gnanasekaran A., Kaginelli S.B., Kuppanna G., Kallappa C.G., Basalingappa K.M. Targeting Notch signalling pathway of cancer stem cells. Stem Cell Investig. 2018;5 doi: 10.21037/sci.2018.02.02.", "ArticleIdList": ["10.21037/sci.2018.02.02", "PMC5897708", "29682512"]}, {"Citation": "Rizzo P., Osipo C., Foreman K., Golde T., Osborne B., Miele L. Rational targeting of Notch signaling in cancer. Oncogene. 2008;27:5124\u20135131.", "ArticleIdList": ["18758481"]}, {"Citation": "Curry C.L., Reed L.L., Golde T.E., Miele L., Nickoloff B.J., Foreman K.E. Gamma secretase inhibitor blocks Notch activation and induces apoptosis in Kaposi\u2019s sarcoma tumor cells. Oncogene. 2005;24:6333\u20136344. doi: 10.1038/sj.onc.1208783.", "ArticleIdList": ["10.1038/sj.onc.1208783", "15940249"]}, {"Citation": "Andersson E.R., Lendahl U. Therapeutic modulation of Notch signalling\u2014are we there yet? Nat. Rev. Drug Discov. 2014;13:357\u2013378.", "ArticleIdList": ["24781550"]}, {"Citation": "Orza A., Casciano D., Biris A. Nanomaterials for targeted drug delivery to cancer stem cells. Drug Metab. Rev. 2014;46:191\u2013206. doi: 10.3109/03602532.2014.900566.", "ArticleIdList": ["10.3109/03602532.2014.900566", "24697156"]}, {"Citation": "Nie P., Vartak A., Li Y.M. \u03b3-Secretase inhibitors and modulators: Mechanistic insights into the function and regulation of \u03b3-Secretase. Semin. Cell Dev. Biol. 2020;105:43\u201353. doi: 10.1016/j.semcdb.2020.03.002.", "ArticleIdList": ["10.1016/j.semcdb.2020.03.002", "PMC7483676", "32249070"]}, {"Citation": "Pine S.R. Rethinking Gamma-secretase Inhibitors for Treatment of Non\u2013small-Cell Lung Cancer: Is notch the target? Clin. Cancer Res. 2018;68:7\u201330. doi: 10.1158/1078-0432.CCR-18-1635.", "ArticleIdList": ["10.1158/1078-0432.CCR-18-1635", "PMC6295228", "30104200"]}, {"Citation": "Golde T.E., Koo E.H., Felsenstein K.M., Osborne B.A., Miele L. \u03b3-Secretase inhibitors and modulators. Biochim. Biophys. Acta\u2014Biomater. 2013;1828:2898\u20132907. doi: 10.1016/j.bbamem.2013.06.005.", "ArticleIdList": ["10.1016/j.bbamem.2013.06.005", "PMC3857966", "23791707"]}, {"Citation": "Allenspach E.J., Maillard I., Aster J.C., Pear W.S. Notch signaling in cancer. Cancer Biol. Ther. 2002;1:466\u2013476. doi: 10.4161/cbt.1.5.159.", "ArticleIdList": ["10.4161/cbt.1.5.159", "12496471"]}, {"Citation": "Ellisen L.W., Bird J., West D.C., Soreng A.L., Reynolds T.C., Smith S.D., Sklar J. TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell. 1991;66:649\u2013661. doi: 10.1016/0092-8674(91)90111-B.", "ArticleIdList": ["10.1016/0092-8674(91)90111-B", "1831692"]}, {"Citation": "Fabbri G., Rasi S., Rossi D., Trifonov V., Khiabanian H., Ma J., Grunn A., Fangazio M., Capello D., Monti S., et al. Analysis of the chronic lymphocytic leukemia coding genome: Role of NOTCH1 mutational activation. J. Exp. Med. 2011;208:1389\u20131401. doi: 10.1084/jem.20110921.", "ArticleIdList": ["10.1084/jem.20110921", "PMC3135373", "21670202"]}, {"Citation": "Houde C., Li Y., Song L., Barton K., Zhang Q., Godwin J., Nand S., Toor A., Alkan S., Smadja N.V., et al. Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines. Blood. 2004;104:3697\u20133704. doi: 10.1182/blood-2003-12-4114.", "ArticleIdList": ["10.1182/blood-2003-12-4114", "15292061"]}, {"Citation": "Guo S., Liu M., Gonzalez-Perez R.R. Role of Notch and its oncogenic signaling crosstalk in breast cancer. Biochim. Biophys. Acta\u2014Rev. Cancer. 2011;1815:197\u2013213.", "ArticleIdList": ["PMC3060666", "21193018"]}, {"Citation": "Song L.L., Peng Y., Yun J., Rizzo P., Chaturvedi V., Weijzen S., Kast W.M., Stone P.J.B., Santos L., Loredo A., et al. Notch-1 associates with IKK\u03b1 and regulates IKK activity in cervical cancer cells. Oncogene. 2008;27:5833\u20135844. doi: 10.1038/onc.2008.190.", "ArticleIdList": ["10.1038/onc.2008.190", "18560356"]}, {"Citation": "Miele L., Miao H., Nickoloff B.J. NOTCH signaling as a novel cancer therapeutic target. Curr. Cancer Drug Targets. 2006;6:313\u2013323. doi: 10.2174/156800906777441771.", "ArticleIdList": ["10.2174/156800906777441771", "16848722"]}, {"Citation": "Gu K., Li Q., Lin H., Zhu J., Mo J., He S., Lu X., Jiang X., Sun H. Gamma secretase inhibitors: A patent review (2013-2015) Expert Opin. Ther. Pat. 2017;27:851\u2013866. doi: 10.1080/13543776.2017.1313231.", "ArticleIdList": ["10.1080/13543776.2017.1313231", "28350212"]}, {"Citation": "Hyde L.A., McHugh N.A., Chen J., Zhang Q., Manfra D., Nomeir A.A., Josien H., Bara T., Clader J.W., Zhang L. Studies to investigate the in vivo therapeutic window of the \u03b3-secretase inhibitor N2-[(2S)-2-(3, 5-difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6-oxo-6, 7-dihydro-5H-dibenzo [b, d] azepin-7-yl]-L-alaninamide (LY411, 575) in the CRND8 mouse. J. Pharmacol. Exp. Ther. 2006;319:1133\u20131143. doi: 10.1124/jpet.106.111716.", "ArticleIdList": ["10.1124/jpet.106.111716", "16946102"]}, {"Citation": "Zhou B.-B.S., Zhang H., Damelin M., Geles K.G., Grindley J.C., Dirks P.B. Tumour-initiating cells: Challenges and opportunities for anticancer drug discovery. Nat. Rev. Drug Discov. 2009;8:806\u2013823. doi: 10.1038/nrd2137.", "ArticleIdList": ["10.1038/nrd2137", "19794444"]}, {"Citation": "Kolb E.A., Gorlick R., Keir S.T., Maris J.M., Lock R., Carol H., Kurmasheva R.T., Reynolds C.P., Kang M.H., Wu J. Initial testing (stage 1) by the pediatric preclinical testing program of RO4929097, a \u03b3-secretase inhibitor targeting notch signaling. Pediatr. Blood Cancer. 2012;58:815\u2013818. doi: 10.1002/pbc.23290.", "ArticleIdList": ["10.1002/pbc.23290", "PMC3276746", "22052798"]}, {"Citation": "Zhang C.C., Pavlicek A., Zhang Q., Lira M.E., Painter C.L., Yan Z., Zheng X., Lee N.V., Ozeck M., Qiu M. Biomarker and pharmacologic evaluation of the \u03b3-secretase inhibitor PF-03084014 in breast cancer models. Clin. Cancer Res. 2012;18:5008\u20135019. doi: 10.1158/1078-0432.CCR-12-1379.", "ArticleIdList": ["10.1158/1078-0432.CCR-12-1379", "22806875"]}, {"Citation": "Akiyoshi T., Nakamura M., Yanai K., Nagai S., Wada J., Koga K., Nakashima H., Sato N., Tanaka M., Katano M. \u03b3-Secretase inhibitors enhance taxane-induced mitotic arrest and apoptosis in colon cancer cells. Gastroenterology. 2008;134:131\u2013144. doi: 10.1053/j.gastro.2007.10.008.", "ArticleIdList": ["10.1053/j.gastro.2007.10.008", "18166351"]}, {"Citation": "Aleksic T., Feller S.M. Gamma-secretase inhibition combined with platinum compounds enhances cell death in a large subset of colorectal cancer cells. Cell Commun. Signal. 2008;6:8. doi: 10.1186/1478-811X-6-8.", "ArticleIdList": ["10.1186/1478-811X-6-8", "PMC2584637", "18950493"]}, {"Citation": "Pellegrinet L., Rodilla V., Liu Z., Chen S., Koch U., Espinosa L., Kaestner K.H., Kopan R., Lewis J., Radtke F. Dll1-and dll4-mediated notch signaling are required for homeostasis of intestinal stem cells. Gastroenterology. 2011;140:1230\u20131240. doi: 10.1053/j.gastro.2011.01.005.", "ArticleIdList": ["10.1053/j.gastro.2011.01.005", "PMC3066401", "21238454"]}, {"Citation": "Efferson C.L., Winkelmann C.T., Ware C., Sullivan T., Giampaoli S., Tammam J., Patel S., Mesiti G., Reilly J.F., Gibson R.E. Downregulation of Notch pathway by a \u03b3-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model. Cancer Res. 2010;70:2476\u20132484. doi: 10.1158/0008-5472.CAN-09-3114.", "ArticleIdList": ["10.1158/0008-5472.CAN-09-3114", "20197467"]}, {"Citation": "Schott A.F., Landis M.D., Dontu G., Griffith K.A., Layman R.M., Krop I., Paskett L.A., Wong H., Dobrolecki L.E., Lewis M.T., et al. Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors. Clin. Cancer Res. 2013;19:1512\u20131524. doi: 10.1158/1078-0432.CCR-11-3326.", "ArticleIdList": ["10.1158/1078-0432.CCR-11-3326", "PMC3602220", "23340294"]}, {"Citation": "Moher D., Liberati A., Tetzlaff J., Altman D.G., Group P. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009;6:e1000097. doi: 10.1371/journal.pmed.1000097.", "ArticleIdList": ["10.1371/journal.pmed.1000097", "PMC2707599", "19621072"]}, {"Citation": "Panaccione A., Chang M.T., Carbone B.E., Guo Y., Moskaluk C.A., Virk R.K., Chiriboga L., Prasad M.L., Judson B., Mehra S., et al. NOTCH1 and SOX10 are essential for proliferation and radiation resistance of cancer stem-like cells in adenoid cystic carcinoma. Clin. Cancer Res. 2016;22:2083\u20132095. doi: 10.1158/1078-0432.CCR-15-2208.", "ArticleIdList": ["10.1158/1078-0432.CCR-15-2208", "PMC4834904", "27084744"]}, {"Citation": "Wang Y., Liu Y., Malek S.N., Zheng P., Liu Y. Targeting HIF1\u03b1 eliminates cancer stem cells in hematological malignancies. Cell Stem Cell. 2011;8:399\u2013411. doi: 10.1016/j.stem.2011.02.006.", "ArticleIdList": ["10.1016/j.stem.2011.02.006", "PMC3084595", "21474104"]}, {"Citation": "Ikram M., Lim Y., Baek S.Y., Jin S., Jeong Y.H., Kwak J.Y., Yoon S. Co-targeting of Tiam1/Rac1 and Notch ameliorates chemoresistance against doxorubicin in a biomimetic 3D lymphoma model. Oncotarget. 2018;9:2058\u20132075. doi: 10.18632/oncotarget.23156.", "ArticleIdList": ["10.18632/oncotarget.23156", "PMC5788621", "29416753"]}, {"Citation": "Gal H., Amariglio N., Trakhtenbrot L., Jacob-Hirsh J., Margalit O., Avigdor A., Nagler A., Tavor S., Ein-Dor L., Lapidot T., et al. Gene expression profiles of AML derived stem cells; similarity to hematopoietic stem cells. Leukemia. 2006;20:2147\u20132154. doi: 10.1038/sj.leu.2404401.", "ArticleIdList": ["10.1038/sj.leu.2404401", "17039238"]}, {"Citation": "Tatarek J., Cullion K., Ashworth T., Gerstein R., Aster J.C., Kelliher M.A. Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL. Blood. 2011;118:1579\u20131590. doi: 10.1182/blood-2010-08-300343.", "ArticleIdList": ["10.1182/blood-2010-08-300343", "PMC3156046", "21670468"]}, {"Citation": "Okuhashi Y., Itoh M., Nara N., Tohda S. Effects of combination of notch inhibitor plus hedgehog inhibitor or Wnt inhibitor on growth of leukemia cells. Anticancer Res. 2011;31:893\u2013906.", "ArticleIdList": ["21498710"]}, {"Citation": "Okuhashi Y., Itoh M., Arai A., Nara N., Tohda S. \u03b3-secretase inhibitors induce erythroid differentiation in erythroid leukemia cell lines. Anticancer Res. 2010;30:4071\u20134074.", "ArticleIdList": ["21036721"]}, {"Citation": "Issa M.E., Berndt S., Carpentier G., Pezzuto J.M., Cuendet M. Bruceantin inhibits multiple myeloma cancer stem cell proliferation. Cancer Biol. Ther. 2016;17:966\u2013975. doi: 10.1080/15384047.2016.1210737.", "ArticleIdList": ["10.1080/15384047.2016.1210737", "PMC5036415", "27434731"]}, {"Citation": "Hu Y.Y., Fu L.A., Li S.Z., Chen Y., Li J.C., Han J., Liang L., Li L., Ji C.C., Zheng M.H., et al. Hif-1\u03b1 and Hif-2\u03b1 differentially regulate Notch signaling through competitive interaction with the intracellular domain of Notch receptors in glioma stem cells. Cancer Lett. 2014;314:67\u201376. doi: 10.1016/j.canlet.2014.03.035.", "ArticleIdList": ["10.1016/j.canlet.2014.03.035", "24705306"]}, {"Citation": "Li Y., He Z.C., Zhang X.N., Liu Q., Chen C., Zhu Z., Chen Q., Shi Y., Yao X.H., Cui Y.H., et al. Stanniocalcin-1 augments stem-like traits of glioblastoma cells through binding and activating NOTCH1. Cancer Lett. 2018;416:66\u201374. doi: 10.1016/j.canlet.2017.11.033.", "ArticleIdList": ["10.1016/j.canlet.2017.11.033", "29196129"]}, {"Citation": "Liu X., Xu Q.R., Xie W.F., Wang M. De DAPT suppresses the proliferation of human glioma cell line SHG-44. Asian Pac. J. Trop. Med. 2014;7:552\u2013556. doi: 10.1016/S1995-7645(14)60092-4.", "ArticleIdList": ["10.1016/S1995-7645(14)60092-4", "25063285"]}, {"Citation": "Wang R., Chadalavada K., Wilshire J., Kowalik U., Hovinga K.E., Geber A., Fligelman B., Leversha M., Brennan C., Tabar V. Glioblastoma stem-like cells give rise to tumour endothelium. Nature. 2010;468:829\u2013835. doi: 10.1038/nature09624.", "ArticleIdList": ["10.1038/nature09624", "21102433"]}, {"Citation": "Kristoffersen K., Villingsh\u00f8j M., Poulsen H.S., Stockhausen M.T. Level of Notch activation determines the effect on growth and stem cell-like features in glioblastoma multiforme neurosphere cultures. Cancer Biol. Ther. 2013;14:625\u2013637. doi: 10.4161/cbt.24595.", "ArticleIdList": ["10.4161/cbt.24595", "PMC3742492", "23792644"]}, {"Citation": "Pistollato F., Rampazzo E., Persano L., Abbadi S., Frasson C., Denaro L., D\u2019Avella D., Panchision D.M., Puppa A.D., Scienza R., et al. Interaction of hypoxia-inducible factor-1\u03b1 and Notch signaling regulates medulloblastoma precursor proliferation and fate. Stem Cells. 2010;28:1918\u20131929. doi: 10.1002/stem.518.", "ArticleIdList": ["10.1002/stem.518", "PMC3474900", "20827750"]}, {"Citation": "Kristoffersen K., Nedergaard M.K., Villingsh\u00f8j M., Borup R., Broholm H., Kj\u00e6r A., Poulsen H.S., Stockhausen M.T. Inhibition of Notch signaling alters the phenotype of orthotopic tumors formed from glioblastoma multiforme neurosphere cells but does not hamper intracranial tumor growth regardless of endogene Notch pathway signature. Cancer Biol. Ther. 2014;15:862\u2013877. doi: 10.4161/cbt.28876.", "ArticleIdList": ["10.4161/cbt.28876", "PMC4100987", "24755988"]}, {"Citation": "Shen Y., Chen H., Zhang J., Chen Y., Wang M., Ma J., Hong L., Liu N., Fan Q., Lu X., et al. Increased Notch signaling enhances radioresistance of malignant stromal cells induced by glioma stem/progenitor cells. PLoS ONE. 2015;10:e0142594. doi: 10.1371/journal.pone.0142594.", "ArticleIdList": ["10.1371/journal.pone.0142594", "PMC4657951", "26599017"]}, {"Citation": "Gal H., Makovitzki A., Amariglio N., Rechavi G., Ram Z., Givol D. A rapid assay for drug sensitivity of glioblastoma stem cells. Biochem. Biophys. Res. Commun. 2007;12:1205\u20131219. doi: 10.1016/j.bbrc.2007.05.020.", "ArticleIdList": ["10.1016/j.bbrc.2007.05.020", "17512905"]}, {"Citation": "Wang Y., Wang Y., Chen H., Liang Q. Endothelial Cells Promote Formation of Medulloblastoma Stem-Like Cells via Notch Pathway Activation. J. Mol. Neurosci. 2017;63:152\u2013158. doi: 10.1007/s12031-017-0965-2.", "ArticleIdList": ["10.1007/s12031-017-0965-2", "28856557"]}, {"Citation": "Kanabur P., Guo S., Simonds G.R., Kelly D.F., Gourdie R.G., Verbridge S.S., Sheng Z. Patient-derived glioblastoma stem cells respond differentially to targeted therapies. Oncotarget. 2016;7:86406\u201386419. doi: 10.18632/oncotarget.13415.", "ArticleIdList": ["10.18632/oncotarget.13415", "PMC5349922", "27863440"]}, {"Citation": "Floyd D.H., Kefas B., Seleverstov O., Mykhaylyk O., Dominguez C., Comeau L., Plank C., Purow B. Alpha-secretase inhibition reduces human glioblastoma stem cell growth in vitro and in vivo by inhibiting Notch. Neuro. Oncol. 2012;14:1215\u20131226. doi: 10.1093/neuonc/nos157.", "ArticleIdList": ["10.1093/neuonc/nos157", "PMC3452340", "22962413"]}, {"Citation": "Park N.I., Guilhamon P., Desai K., McAdam R.F., Langille E., O\u2019Connor M., Lan X., Whetstone H., Coutinho F.J., Vanner R.J., et al. ASCL1 Reorganizes Chromatin to Direct Neuronal Fate and Suppress Tumorigenicity of Glioblastoma Stem Cells. Cell Stem Cell. 2017;21:209\u2013224. doi: 10.1016/j.stem.2017.06.004.", "ArticleIdList": ["10.1016/j.stem.2017.06.004", "28712938"]}, {"Citation": "Saito N., Hirai N., Aoki K., Suzuki R., Fujita S., Nakayama H., Hayashi M., Ito K., Sakurai T., Iwabuchi S. The oncogene addiction switch from NOTCH to PI3K requires simultaneous targeting of NOTCH and PI3K pathway inhibition in glioblastoma. Cancers (Basel) 2019;11:121. doi: 10.3390/cancers11010121.", "ArticleIdList": ["10.3390/cancers11010121", "PMC6356490", "30669546"]}, {"Citation": "Wang J., Wakeman T.P., Lathia J.D., Hjelmeland A.B., Wang X.F., White R.R., Rich J.N., Sullenger B.A. Notch promotes radioresistance of glioma stem cells. Stem Cells. 2010;28:17\u201328. doi: 10.1002/stem.261.", "ArticleIdList": ["10.1002/stem.261", "PMC2825687", "19921751"]}, {"Citation": "Fan X., Khaki L., Zhu T.S., Soules M.E., Talsma C.E., Gul N., Koh C., Zhang J., Li Y.M., Maciaczyk J., et al. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells. 2010;28:5\u201316. doi: 10.1002/stem.254.", "ArticleIdList": ["10.1002/stem.254", "PMC2878196", "19904829"]}, {"Citation": "Fan X., Matsui W., Khaki L., Stearns D., Chun J., Li Y.M., Eberhart C.G. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res. 2006;66:7445\u20137452. doi: 10.1158/0008-5472.CAN-06-0858.", "ArticleIdList": ["10.1158/0008-5472.CAN-06-0858", "16885340"]}, {"Citation": "Dai L., He J., Liu Y., Byun J., Vivekanandan A., Pennathur S., Fan X., Lubman D.M. Dose-dependent proteomic analysis of glioblastoma cancer stem cells upon treatment with \u03b3-secretase inhibitor. Proteomics. 2011;11:4529\u20134540. doi: 10.1002/pmic.201000730.", "ArticleIdList": ["10.1002/pmic.201000730", "PMC3517080", "21932445"]}, {"Citation": "Charles N., Ozawa T., Squatrito M., Bleau A.M., Brennan C.W., Hambardzumyan D., Holland E.C. Perivascular Nitric Oxide Activates Notch Signaling and Promotes Stem-like Character in PDGF-Induced Glioma Cells. Cell Stem Cell. 2010;6:141\u2013152. doi: 10.1016/j.stem.2010.01.001.", "ArticleIdList": ["10.1016/j.stem.2010.01.001", "PMC3818090", "20144787"]}, {"Citation": "Fornara O., Bartek J., Rahbar A., Odeberg J., Khan Z., Peredo I., Hamerlik P., Bartek J., Stragliotto G., Land\u00e1zuri N., et al. Cytomegalovirus infection induces a stem cell phenotype in human primary glioblastoma cells: Prognostic significance and biological impact. Cell Death Differ. 2016;23:261\u2013269. doi: 10.1038/cdd.2015.91.", "ArticleIdList": ["10.1038/cdd.2015.91", "PMC4716305", "26138445"]}, {"Citation": "Tanaka S., Nakada M., Yamada D., Nakano I., Todo T., Ino Y., Hoshii T., Tadokoro Y., Ohta K., Ali M.A.E., et al. Strong therapeutic potential of \u03b3-secretase inhibitor MRK003 for CD44-high and CD133-low glioblastoma initiating cells. J. Neurooncol. 2015;121:239\u2013250. doi: 10.1007/s11060-014-1630-z.", "ArticleIdList": ["10.1007/s11060-014-1630-z", "25293440"]}, {"Citation": "Natsumeda M., Maitani K., Liu Y., Miyahara H., Kaur H., Chu Q., Zhang H.D., Kahlert U., Eberhart C.G. Targeting Notch Signaling and Autophagy Increases Cytotoxicity in Glioblastoma Neurospheres. Brain Pathol. 2016;26:713\u2013723. doi: 10.1111/bpa.12343.", "ArticleIdList": ["10.1111/bpa.12343", "26613556"]}, {"Citation": "Lin J., Zhang X.M., Yang J.C., Ye Y.B., Luo S.Q. \u03b3-secretase inhibitor-I enhances radiosensitivity of glioblastoma cell lines by depleting CD133+ tumor cells. Arch. Med. Res. 2010;41:519\u2013529. doi: 10.1016/j.arcmed.2010.10.006.", "ArticleIdList": ["10.1016/j.arcmed.2010.10.006", "21167391"]}, {"Citation": "Ulasov I.V., Nandi S., Dey M., Sonabend A.M., Lesniak M.S. Inhibition of sonic hedgehog and notch pathways enhances sensitivity of cd133+ glioma stem cells to temozolomide therapy. Mol. Med. 2011;17:103\u2013112. doi: 10.2119/molmed.2010.00062.", "ArticleIdList": ["10.2119/molmed.2010.00062", "PMC3022974", "20957337"]}, {"Citation": "Pietras A., Katz A.M., Ekstr\u00f6m E.J., Wee B., Halliday J.J., Pitter K.L., Werbeck J.L., Amankulor N.M., Huse J.T., Holland E.C. Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth. Cell Stem Cell. 2014;14:357\u2013369. doi: 10.1016/j.stem.2014.01.005.", "ArticleIdList": ["10.1016/j.stem.2014.01.005", "PMC3999042", "24607407"]}, {"Citation": "Ma Y., Cheng Z., Liu J., Torre-Healy L., Lathia J.D., Nakano I., Guo Y., Thompson R.C., Freeman M.L., Wang J. Inhibition of Farnesyltransferase Potentiates NOTCH-Targeted Therapy against Glioblastoma Stem Cells. Stem Cell Rep. 2017;9:1948\u20131960. doi: 10.1016/j.stemcr.2017.10.028.", "ArticleIdList": ["10.1016/j.stemcr.2017.10.028", "PMC5785731", "29198824"]}, {"Citation": "Hu Y.Y., Zheng M.H., Cheng G., Li L., Liang L., Gao F., Wei Y.N., Fu L.A., Han H. Notch signaling contributes to the maintenance of both normal neural stem cells and patient-derived glioma stem cells. BMC Cancer. 2011;11:82. doi: 10.1186/1471-2407-11-82.", "ArticleIdList": ["10.1186/1471-2407-11-82", "PMC3052197", "21342503"]}, {"Citation": "Dai L., Liu Y., He J., Flack C.G., Talsma C.E., Crowley J.G., Muraszko K.M., Fan X., Lubman D.M. Differential profiling studies of N-linked glycoproteins in glioblastoma cancer stem cells upon treatment with \u03b3-secretase inhibitor. Proteomics. 2011;11:4021\u20134028. doi: 10.1002/pmic.201100014.", "ArticleIdList": ["10.1002/pmic.201100014", "PMC3235004", "21898824"]}, {"Citation": "Ding X., Ding C., Wang F., Deng W., Yu M., Meng Q., Sun P. Effects of NOTCH1 signaling inhibitor \u03b3-secretase inhibitor II on growth of cancer stem cells. Oncol. Lett. 2018;16:6095\u20136099. doi: 10.3892/ol.2018.9377.", "ArticleIdList": ["10.3892/ol.2018.9377", "PMC6202534", "30405755"]}, {"Citation": "Hsu E.C., Kulp S.K., Huang H.L., Tu H.J., Salunke S.B., Sullivan N.J., Sun D., Wicha M.S., Shapiro C.L., Chen C.S. Function of integrin-linked kinase in modulating the stemness of il-6-abundant breast cancer cells by regulating \u03b3-secretase-mediated notch1 activation in caveolae. Neoplasia (U. S.) 2015;17:497\u2013508. doi: 10.1016/j.neo.2015.06.001.", "ArticleIdList": ["10.1016/j.neo.2015.06.001", "PMC4719004", "26152358"]}, {"Citation": "Chen J.H., Kuo K.T., Bamodu O.A., Lin Y.C., Yang R.B., Yeh C.T., Chao T.Y. Upregulated SCUBE2 expression in breast cancer stem cells enhances triple negative breast cancer aggression through modulation of notch signaling and epithelial-to-mesenchymal transition. Exp. Cell Res. 2018;370:444\u2013453. doi: 10.1016/j.yexcr.2018.07.008.", "ArticleIdList": ["10.1016/j.yexcr.2018.07.008", "29981340"]}, {"Citation": "Cho Y., Lee H.W., Kang H.G., Kim H.Y., Kim S.J., Chun K.H. Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer. Oncotarget. 2015;6:8709\u20138721. doi: 10.18632/oncotarget.3325.", "ArticleIdList": ["10.18632/oncotarget.3325", "PMC4496178", "25909162"]}, {"Citation": "Li W., Yang H., Li X., Han L., Xu N., Shi A. Signaling pathway inhibitors target breast cancer stem cells in triple-negative breast cancer. Oncol. Rep. 2019;41:437\u2013446. doi: 10.3892/or.2018.6805.", "ArticleIdList": ["10.3892/or.2018.6805", "30365081"]}, {"Citation": "Tao L., Roberts A.L., Dunphy K.A., Bigelow C., Yan H., Jerry D.J. Repression of mammary stem/progenitor cells by p53 is mediated by notch and separable from apoptotic activity. Stem Cells. 2011;29:119\u2013127. doi: 10.1002/stem.552.", "ArticleIdList": ["10.1002/stem.552", "PMC3404152", "21280161"]}, {"Citation": "McGowan P.M., Simedrea C., Ribot E.J., Foster P.J., Palmieri D., Steeg P.S., Allan A.L., Chambers A.F. Notch1 inhibition alters the CD44 hi/CD24 lo population and reduces the formation of brain metastases from breast cancer. Mol. Cancer Res. 2011;9:834\u2013844. doi: 10.1158/1541-7786.MCR-10-0457.", "ArticleIdList": ["10.1158/1541-7786.MCR-10-0457", "PMC3140630", "21665937"]}, {"Citation": "Xing F., Okuda H., Watabe M., Kobayashi A., Pai S.K., Liu W., Pandey P.R., Fukuda K., Hirota S., Sugai T., et al. Hypoxia-induced Jagged2 promotes breast cancer metastasis and self-renewal of cancer stem-like cells. Oncogene. 2011;30:4075\u20134086. doi: 10.1038/onc.2011.122.", "ArticleIdList": ["10.1038/onc.2011.122", "PMC3145824", "21499308"]}, {"Citation": "Boelens M.C., Wu T.J., Nabet B.Y., Xu B., Qiu Y., Yoon T., Azzam D.J., Twyman-Saint Victor C., Wiemann B.Z., Ishwaran H., et al. Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways. Cell. 2014;159:499\u2013513. doi: 10.1016/j.cell.2014.09.051.", "ArticleIdList": ["10.1016/j.cell.2014.09.051", "PMC4283810", "25417103"]}, {"Citation": "Farnie G., Willan P.M., Clarke R.B., Bundred N.J. Combined Inhibition of ErbB1/2 and Notch Receptors Effectively Targets Breast Ductal Carcinoma In Situ (DCIS) Stem/Progenitor Cell Activity Regardless of ErbB2 Status. PLoS ONE. 2013;8:e56840. doi: 10.1371/journal.pone.0056840.", "ArticleIdList": ["10.1371/journal.pone.0056840", "PMC3572946", "23457626"]}, {"Citation": "Harrison H., Sim\u00f5es B.M., Rogerson L., Howell S.J., Landberg G., Clarke R.B. Oestrogen increases the activity of oestrogen receptor negative breast cancer stem cells through paracrine EGFR and Notch signalling. Breast Cancer Res. 2013;15:R21. doi: 10.1186/bcr3396.", "ArticleIdList": ["10.1186/bcr3396", "PMC3672803", "23497505"]}, {"Citation": "Buckley N.E., Nic An Tsaoir C.B., Blayney J.K., Oram L.C., Crawford N.T., D\u2019Costa Z.C., Quinn J.E., Kennedy R.D., Harkin D.P., Mullan P.B. BRCA1 is a key regulator of breast differentiation through activation of Notch signalling with implications for anti-endocrine treatment of breast cancers. Nucleic Acids Res. 2013;41:8601\u20138614. doi: 10.1093/nar/gkt626.", "ArticleIdList": ["10.1093/nar/gkt626", "PMC3794588", "23863842"]}, {"Citation": "Ray A., Vasudevan S., Sengupta S. 6-shogaol inhibits breast cancer cells and stem cell-like spheroids by modulation of notch signaling pathway and induction of autophagic cell death. PLoS ONE. 2015:e0137614. doi: 10.1371/journal.pone.0137614.", "ArticleIdList": ["10.1371/journal.pone.0137614", "PMC4565635", "26355461"]}, {"Citation": "Mamaeva V., Niemi R., Beck M., \u00d6zliseli E., Desai D., Landor S., Gronroos T., Kronqvist P., Pettersen I.K.N., McCormack E. Inhibiting notch activity in breast cancer stem cells by glucose functionalized nanoparticles carrying \u03b3-secretase inhibitors. Mol. Ther. 2016;24:926\u2013936. doi: 10.1038/mt.2016.42.", "ArticleIdList": ["10.1038/mt.2016.42", "PMC4881775", "26916284"]}, {"Citation": "Phillips T.M., Kim K., Vlashi E., McBride W.H., Pajonk F. Effects of recombinant erythropoietin on breast cancer-initiating cells. Neoplasia. 2007;9:1122\u20131129. doi: 10.1593/neo.07694.", "ArticleIdList": ["10.1593/neo.07694", "PMC2134908", "18084619"]}, {"Citation": "Lagadec C., Vlashi E., Alhiyari Y., Phillips T.M., Bochkur Dratver M., Pajonk F. Radiation-induced notch signaling in breast cancer stem cells. Int. J. Radiat. Oncol. Biol. Phys. 2013;87:609\u2013618. doi: 10.1016/j.ijrobp.2013.06.2064.", "ArticleIdList": ["10.1016/j.ijrobp.2013.06.2064", "PMC3788036", "23992604"]}, {"Citation": "Luo M., Shang L., Brooks M.D., Jiagge E., Zhu Y., Buschhaus J.M., Conley S., Fath M.A., Davis A., Gheordunescu E., et al. Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling. Cell Metab. 2018;28:69\u201386. doi: 10.1016/j.cmet.2018.06.006.", "ArticleIdList": ["10.1016/j.cmet.2018.06.006", "PMC6037414", "29972798"]}, {"Citation": "Shah D., Wyatt D., Baker A.T., Simms P., Peiffer D.S., Fernandez M., Rakha E., Green A., Filipovic A., Miele L., et al. Inhibition of her2 increases jagged1-dependent breast cancer stem cells: Role for membrane jagged1. Clin. Cancer Res. 2018;24:4566\u20134578. doi: 10.1158/1078-0432.CCR-17-1952.", "ArticleIdList": ["10.1158/1078-0432.CCR-17-1952", "PMC6139046", "29895705"]}, {"Citation": "D\u2019Angelo R.C., Ouzounova M., Davis A., Choi D., Tchuenkam S.M., Kim G., Luther T., Quraishi A.A., Senbabaoglu Y., Conley S.J., et al. Notch reporter activity in breast cancer cell lines identifies a subset of cells with stem cell activity. Mol. Cancer Ther. 2015;14:779\u2013787. doi: 10.1158/1535-7163.MCT-14-0228.", "ArticleIdList": ["10.1158/1535-7163.MCT-14-0228", "PMC4456218", "25673823"]}, {"Citation": "Kondratyev M., Kreso A., Hallett R.M., Girgis-Gabardo A., Barcelon M.E., Ilieva D., Ware C., Majumder P.K., Hassell J.A. Gamma-secretase inhibitors target tumor-initiating cells in a mouse model of ERBB2 breast cancer. Oncogene. 2012;31:93\u2013103. doi: 10.1038/onc.2011.212.", "ArticleIdList": ["10.1038/onc.2011.212", "21666715"]}, {"Citation": "Xing F., Kobayashi A., Okuda H., Watabe M., Pai S.K., Pandey P.R., Hirota S., Wilber A., Mo Y.Y., Moore B.E., et al. Reactive astrocytes promote the metastatic growth of breast cancer stem-like cells by activating Notch signalling in brain. EMBO Mol. Med. 2013;5:384\u2013396. doi: 10.1002/emmm.201201623.", "ArticleIdList": ["10.1002/emmm.201201623", "PMC3598079", "23495140"]}, {"Citation": "McClements L., Yakkundi A., Papaspyropoulos A., Harrison H., Ablett M.P., Jithesh P.V., McKeen H.D., Bennett R., Donley C., Kissenpfennig A., et al. Targeting treatment-resistant breast cancer stem cells with FKBPL and Its peptide derivative, AD-01, via the CD44 pathway. Clin. Cancer Res. 2013;19:3881\u20133893. doi: 10.1158/1078-0432.CCR-13-0595.", "ArticleIdList": ["10.1158/1078-0432.CCR-13-0595", "23741069"]}, {"Citation": "Harrison H., Farnie G., Howell S.J., Rock R.E., Stylianou S., Brennan K.R., Bundred N.J., Clarke R.B. Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor. Cancer Res. 2010;70:709\u2013718. doi: 10.1158/0008-5472.CAN-09-1681.", "ArticleIdList": ["10.1158/0008-5472.CAN-09-1681", "PMC3442245", "20068161"]}, {"Citation": "Grudzien P., Lo S., Albain K.S., Robinson P., Rajan P., Strack P.R., Golde T.E., Miele L., Foreman K.E. Inhibition of notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation. Anticancer Res. 2010;30:3853\u20133867.", "ArticleIdList": ["21036696"]}, {"Citation": "Wang D., Xu J., Liu B., He X., Zhou L., Hu X., Qiao F., Zhang A., Xu X., Zhang H., et al. IL6 blockade potentiates the anti-tumor effects of \u03b3-secretase inhibitors in Notch3-expressing breast cancer. Cell Death Differ. 2018;25:330\u2013339. doi: 10.1038/cdd.2017.162.", "ArticleIdList": ["10.1038/cdd.2017.162", "PMC5762847", "29027990"]}, {"Citation": "Azzam D.J., Zhao D., Sun J., Minn A.J., Ranganathan P., Drews-Elger K., Han X., Picon-Ruiz M., Gilbert C.A., Wander S.A., et al. Triple negative breast cancer initiating cell subsets differ in functional and molecular characteristics and in \u03b3-secretase inhibitor drug responses. EMBO Mol. Med. 2013;5:1502\u20131522. doi: 10.1002/emmm.201302558.", "ArticleIdList": ["10.1002/emmm.201302558", "PMC3799576", "23982961"]}, {"Citation": "Debeb B.G., Cohen E.N., Boley K., Freiter E.M., Li L., Robertson F.M., Reuben J.M., Cristofanilli M., Buchholz T.A., Woodward W.A. Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells. Breast Cancer Res. Treat. 2012;134:495\u2013510. doi: 10.1007/s10549-012-2075-8.", "ArticleIdList": ["10.1007/s10549-012-2075-8", "PMC4545650", "22547109"]}, {"Citation": "Feng Y., Bommer G.T., Zhao J., Green M., Sands E., Zhai Y., Brown K., Burberry A., Cho K.R., Fearon E.R. Mutant kras promotes hyperplasia and alters differentiation in the colon epithelium but does not expand the presumptive stem cell pool. Gastroenterology. 2011;141:1003\u20131013. doi: 10.1053/j.gastro.2011.05.007.", "ArticleIdList": ["10.1053/j.gastro.2011.05.007", "PMC3163826", "21699772"]}, {"Citation": "Bu P., Wang L., Chen K.Y., Srinivasan T., Murthy P.K.L., Tung K.L., Varanko A.K., Chen H.J., Ai Y., King S., et al. A miR-34a-Numb Feedforward Loop Triggered by Inflammation Regulates Asymmetric Stem Cell Division in Intestine and Colon Cancer. Cell Stem Cell. 2016;18:189\u2013202. doi: 10.1016/j.stem.2016.01.006.", "ArticleIdList": ["10.1016/j.stem.2016.01.006", "PMC4751059", "26849305"]}, {"Citation": "Bu P., Chen K.Y., Chen J.H., Wang L., Walters J., Shin Y.J., Goerger J.P., Sun J., Witherspoon M., Rakhilin N., et al. A microRNA miR-34a-regulated bimodal switch targets notch in colon cancer stem cells. Cell Stem Cell. 2013;12:602\u2013615. doi: 10.1016/j.stem.2013.03.002.", "ArticleIdList": ["10.1016/j.stem.2013.03.002", "PMC3646336", "23642368"]}, {"Citation": "Fender A.W., Nutter J.M., Fitzgerald T.L., Bertrand F.E., Sigounas G. Notch-1 Promotes Stemness and Epithelial to Mesenchymal Transition in Colorectal Cancer. J. Cell. Biochem. 2015;116:2517\u20132527. doi: 10.1002/jcb.25196.", "ArticleIdList": ["10.1002/jcb.25196", "25914224"]}, {"Citation": "Moon C.M., Kwon J.H., Kim J.S., Oh S.H., Jin Lee K., Park J.J., Pil Hong S., Cheon J.H., Kim T.I., Kim W.H. Nonsteroidal anti-inflammatory drugs suppress cancer stem cells via inhibiting PTGS2 (cyclooxygenase 2) and NOTCH/HES1 and activating PPARG in colorectal cancer. Int. J. Cancer. 2014;134:519\u2013529. doi: 10.1002/ijc.28381.", "ArticleIdList": ["10.1002/ijc.28381", "23852449"]}, {"Citation": "Lu J., Ye X., Fan F., Xia L., Bhattacharya R., Bellister S., Tozzi F., Sceusi E., Zhou Y., Tachibana I., et al. Endothelial Cells Promote the Colorectal Cancer Stem Cell Phenotype through a Soluble Form of Jagged-1. Cancer Cell. 2013;23:171\u2013185. doi: 10.1016/j.ccr.2012.12.021.", "ArticleIdList": ["10.1016/j.ccr.2012.12.021", "PMC3574187", "23375636"]}, {"Citation": "Arcaroli J.J., Powell R.W., Varella-Garcia M., McManus M., Tan A.C., Quackenbush K.S., Pitts T.M., Gao D., Spreafico A., Dasari A., et al. ALDH+ tumor-initiating cells exhibiting gain in NOTCH1 gene copy number have enhanced regrowth sensitivity to a \u03b3-secretase inhibitor and irinotecan in colorectal cancer. Mol. Oncol. 2012;6:370\u2013381. doi: 10.1016/j.molonc.2012.03.004.", "ArticleIdList": ["10.1016/j.molonc.2012.03.004", "PMC4033713", "22521243"]}, {"Citation": "Hayakawa Y., Ariyama H., Stancikova J., Sakitani K., Asfaha S., Renz B.W., Dubeykovskaya Z.A., Shibata W., Wang H., Westphalen C.B., et al. Mist1 Expressing Gastric Stem Cells Maintain the Normal and Neoplastic Gastric Epithelium and Are Supported by a Perivascular Stem Cell Niche. Cancer Cell. 2015;28:800\u2013814. doi: 10.1016/j.ccell.2015.10.003.", "ArticleIdList": ["10.1016/j.ccell.2015.10.003", "PMC4684751", "26585400"]}, {"Citation": "Barat S., Chen X., Bui K.C., Bozko P., G\u00f6tze J., Christgen M., Krech T., Malek N.P., Plentz R.R. Gamma-secretase inhibitor IX (GSI) impairs concomitant activation of notch and wnt-beta-catenin pathways in CD441 gastric cancer stem cells. Stem Cells Transl. Med. 2017;6:819\u2013829. doi: 10.1002/sctm.16-0335.", "ArticleIdList": ["10.1002/sctm.16-0335", "PMC5442767", "28186678"]}, {"Citation": "Li L.C., Wang D.L., Wu Y.Z., Nian W.Q., Wu Z.J., Li Y., Ma H.W., Shao J.H. Gastric tumor-initiating CD44+ cells and epithelial-mesenchymal transition are inhibited by \u03b3-secretase inhibitor DAPT. Oncol. Lett. 2015;10:3293\u20133299. doi: 10.3892/ol.2015.3727.", "ArticleIdList": ["10.3892/ol.2015.3727", "PMC4665879", "26722328"]}, {"Citation": "Hong K.J., Wu D.C., Cheng K.H., Chen L.T., Hung W.C. RECK Inhibits Stemness Gene Expression and Tumorigenicity of Gastric Cancer Cells by Suppressing ADAM-Mediated Notch1 Activation. J. Cell. Physiol. 2014;229:191\u2013201. doi: 10.1002/jcp.24434.", "ArticleIdList": ["10.1002/jcp.24434", "23881612"]}, {"Citation": "Kato R., Iwamuro M., Shiraha H., Horiguchi S., Tanaka E., Matsumoto K., Ohyama A., Sawahara H., Nagahara T., Uchida D., et al. Dipeptide \u03b3-secretase inhibitor treatment enhances the anti-tumor effects of cisplatin against gastric cancer by suppressing cancer stem cell properties. Oncol. Lett. 2018;16:5426\u20135432. doi: 10.3892/ol.2018.9301.", "ArticleIdList": ["10.3892/ol.2018.9301", "PMC6144782", "30250614"]}, {"Citation": "Chen H.F., Huang C.H., Liu C.J., Hung J.J., Hsu C.C., Teng S.C., Wu K.J. Twist1 induces endothelial differentiation of tumour cells through the Jagged1-KLF4 axis. Nat. Commun. 2014;5:4697. doi: 10.1038/ncomms5697.", "ArticleIdList": ["10.1038/ncomms5697", "25146389"]}, {"Citation": "Wang Z., Da Silva T.G., Jin K., Han X., Ranganathan P., Zhu X., Sanchez-Mejias A., Bai F., Li B., Fei D.L., et al. Notch signaling drives stemness and tumorigenicity of esophageal adenocarcinoma. Cancer Res. 2014;74:6364\u20136374. doi: 10.1158/0008-5472.CAN-14-2051.", "ArticleIdList": ["10.1158/0008-5472.CAN-14-2051", "PMC4527315", "25164006"]}, {"Citation": "Mendelson J., Song S., Li Y., Maru D.M., Mishra B., Davila M., Hofstetter W.L., Mishra L. Dysfunctional transforming growth factor-\u03b2 signaling with constitutively active notch signaling in Barrett\u2019s esophageal adenocarcinoma. Cancer. 2011;117:3691\u20133702. doi: 10.1002/cncr.25861.", "ArticleIdList": ["10.1002/cncr.25861", "PMC3236645", "21305538"]}, {"Citation": "Zhao Z.L., Zhang L., Huang C.F., Ma S.R., Bu L.L., Liu J.F., Yu G.T., Liu B., Gutkind J.S., Kulkarni A.B., et al. NOTCH1 inhibition enhances the efficacy of conventional chemotherapeutic agents by targeting head neck cancer stem cell. Sci. Rep. 2016;6:24704. doi: 10.1038/srep24704.", "ArticleIdList": ["10.1038/srep24704", "PMC4842967", "27108536"]}, {"Citation": "Upadhyay P., Nair S., Kaur E., Aich J., Dani P., Sethunath V., Gardi N., Chandrani P., Godbole M., Sonawane K., et al. Notch pathway activation is essential for maintenance of stem-like cells in early tongue cancer. Oncotarget. 2016;7:50437\u201350449. doi: 10.18632/oncotarget.10419.", "ArticleIdList": ["10.18632/oncotarget.10419", "PMC5226594", "27391340"]}, {"Citation": "Kawaguchi K., Honda M., Yamashita T., Okada H., Shirasaki T., Nishikawa M., Nio K., Arai K., Sakai Y., Yamashita T., et al. Jagged1 DNA Copy Number Variation Is Associated with Poor Outcome in Liver Cancer. Am. J. Pathol. 2016;24:3145\u20133154. doi: 10.1016/j.ajpath.2016.04.011.", "ArticleIdList": ["10.1016/j.ajpath.2016.04.011", "27315779"]}, {"Citation": "Wu C.X., Xu A., Zhang C.C., Olson P., Chen L., Lee T.K., Cheung T.T., Lo C.M., Wang X.Q. Notch inhibitor PF-03084014 inhibits hepatocellular carcinoma growth and metastasis via suppression of cancer stemness due to reduced activation of Notch1\u2013Stat3. Mol. Cancer Ther. 2017;16:1531\u20131543. doi: 10.1158/1535-7163.MCT-17-0001.", "ArticleIdList": ["10.1158/1535-7163.MCT-17-0001", "28522590"]}, {"Citation": "Cao L., Zhou Y., Zhai B., Liao J., Xu W., Zhang R., Li J., Zhang Y., Chen L., Qian H., et al. Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines. BMC Gastroenterol. 2011;11:71. doi: 10.1186/1471-230X-11-71.", "ArticleIdList": ["10.1186/1471-230X-11-71", "PMC3136412", "21669008"]}, {"Citation": "Yang X., Xia W., Chen L., Wu C.X., Zhang C.C., Olson P., Wang X.Q. Synergistic antitumor effect of a \u03b3-secretase inhibitor PF-03084014 and sorafenib in hepatocellular carcinoma. Oncotarget. 2018;9:34996\u201335007. doi: 10.18632/oncotarget.26209.", "ArticleIdList": ["10.18632/oncotarget.26209", "PMC6201862", "30405889"]}, {"Citation": "Kwon H., Song K., Han C., Zhang J., Lu L., Chen W., Wu T. Epigenetic Silencing of miRNA-34a in Human Cholangiocarcinoma via EZH2 and DNA Methylation: Impact on Regulation of Notch Pathway. Am. J. Pathol. 2017 doi: 10.1016/j.ajpath.2017.06.014.", "ArticleIdList": ["10.1016/j.ajpath.2017.06.014", "PMC5762941", "28923203"]}, {"Citation": "Aoki S., Mizuma M., Takahashi Y., Haji Y., Okada R., Abe T., Karasawa H., Tamai K., Okada T., Morikawa T., et al. Aberrant activation of Notch signaling in extrahepatic cholangiocarcinoma: Clinicopathological features and therapeutic potential for cancer stem cell-like properties. BMC Cancer. 2016;16:854. doi: 10.1186/s12885-016-2919-4.", "ArticleIdList": ["10.1186/s12885-016-2919-4", "PMC5100105", "27821106"]}, {"Citation": "Zheng Y., de la Cruz C.C., Sayles L.C., Alleyne-Chin C., Vaka D., Knaak T.D., Bigos M., Xu Y., Hoang C.D., Shrager J.B., et al. A Rare Population of CD24+ITGB4+Notchhi Cells Drives Tumor Propagation in NSCLC and Requires Notch3 for Self-Renewal. Cancer Cell. 2013;24:59\u201374. doi: 10.1016/j.ccr.2013.05.021.", "ArticleIdList": ["10.1016/j.ccr.2013.05.021", "PMC3923526", "23845442"]}, {"Citation": "Liu Y.P., Yang C.J., Huang M.S., Yeh C.T., Wu A.T.H., Lee Y.C., Lai T.C., Lee C.H., Hsiao Y.W., Lu J., et al. Cisplatin selects for multidrug-resistant CD133+ cells in lung adenocarcinoma by activating notch signaling. Cancer Res. 2013;73:406\u2013416. doi: 10.1158/0008-5472.CAN-12-1733.", "ArticleIdList": ["10.1158/0008-5472.CAN-12-1733", "23135908"]}, {"Citation": "Cai H., Lu W., Zhang Y., Liu H., Wang Z., Shen Y. Specific inhibition of Notch1 signaling suppresses properties of lung cancer stem cells. J. Cancer Res. Ther. 2019;15:1547\u20131552. doi: 10.4103/jcrt.JCRT_482_17.", "ArticleIdList": ["10.4103/jcrt.JCRT_482_17", "31939436"]}, {"Citation": "Sullivan J.P., Spinola M., Dodge M., Raso M.G., Behrens C., Gao B., Schuster K., Shao C., Larsen J.E., Sullivan L.A., et al. Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling. Cancer Res. 2010;70:9937\u20139948. doi: 10.1158/0008-5472.CAN-10-0881.", "ArticleIdList": ["10.1158/0008-5472.CAN-10-0881", "PMC3058307", "21118965"]}, {"Citation": "Mao Z., Liu J., Mao Z., Huang J., Xie S., Liu T. Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy. Biochem. Biophys. Res. Commun. 2014;444:670\u2013675. doi: 10.1016/j.bbrc.2014.01.164.", "ArticleIdList": ["10.1016/j.bbrc.2014.01.164", "24502949"]}, {"Citation": "Zhang Y., Xu W., Guo H., Zhang Y., He Y., Lee S.H., Song X., Li X., Guo Y., Zhao Y., et al. NOTCH1 signaling regulates self-renewal and platinum chemoresistance of cancer stem-like cells in human non-small cell lung cancer. Cancer Res. 2017;77:3082\u20133091. doi: 10.1158/0008-5472.CAN-16-1633.", "ArticleIdList": ["10.1158/0008-5472.CAN-16-1633", "28416482"]}, {"Citation": "Hassan K.A., Wang L., Korkaya H., Chen G., Maillard I., Beer D.G., Kalemkerian G.P., Wicha M.S. Notch pathway activity identifies cells with cancer stem cell-like properties and correlates with worse survival in lung adenocarcinoma. Clin. Cancer Res. 2013;19:1972\u20131980. doi: 10.1158/1078-0432.CCR-12-0370.", "ArticleIdList": ["10.1158/1078-0432.CCR-12-0370", "PMC3630232", "23444212"]}, {"Citation": "Arasada R.R., Amann J.M., Rahman M.A., Huppert S.S., Carbone D.P. EGFR blockade enriches for lung cancer stem-like cells through Notch3-dependent signaling. Cancer Res. 2014;74:5572\u20135584. doi: 10.1158/0008-5472.CAN-13-3724.", "ArticleIdList": ["10.1158/0008-5472.CAN-13-3724", "PMC4263272", "25125655"]}, {"Citation": "Ali S.A., Justilien V., Jamieson L., Murray N.R., Fields A.P. Protein Kinase C\u03b9 Drives a NOTCH3-dependent Stem-like Phenotype in Mutant KRAS Lung Adenocarcinoma. Cancer Cell. 2016;29:367\u2013378. doi: 10.1016/j.ccell.2016.02.012.", "ArticleIdList": ["10.1016/j.ccell.2016.02.012", "PMC4795153", "26977885"]}, {"Citation": "Patenaude A., Woerher S., Umlandt P., Wong F., Ibrahim R., Kyle A., Unger S., Fuller M., Parker J., Minchinton A., et al. A novel population of local pericyte precursor cells in tumor stroma that require Notch signaling for differentiation. Microvasc. Res. 2015;101:38\u201347. doi: 10.1016/j.mvr.2015.05.004.", "ArticleIdList": ["10.1016/j.mvr.2015.05.004", "26092680"]}, {"Citation": "Kumar D., Kumar S., Gorain M., Tomar D., Patil H.S., Radharani N.N.V., Kumar T.V.S., Patil T.V., Thulasiram H.V., Kundu G.C. Notch1-MAPK Signaling Axis Regulates CD133+ Cancer Stem Cell-Mediated Melanoma Growth and Angiogenesis. J. Investig. Dermatol. 2016;136:2462\u20132474. doi: 10.1016/j.jid.2016.07.024.", "ArticleIdList": ["10.1016/j.jid.2016.07.024", "27476721"]}, {"Citation": "Mukherjee N., Almeida A., Partyka K.A., Lu Y., Schwan J.V., Lambert K., Rogers M., Robinson W.A., Robinson S.E., Applegate A.J., et al. Combining a GSI and BCL-2 inhibitor to overcome melanoma\u2019s resistance to current treatments. Oncotarget. 2016;7:84594\u201384607. doi: 10.18632/oncotarget.13141.", "ArticleIdList": ["10.18632/oncotarget.13141", "PMC5356684", "27829238"]}, {"Citation": "Lin X., Sun B., Zhu D., Zhao X., Sun R., Zhang Y., Zhang D., Dong X., Gu Q., Li Y., et al. Notch4+ cancer stem-like cells promote the metastatic and invasive ability of melanoma. Cancer Sci. 2016;107:1079\u20131091. doi: 10.1111/cas.12978.", "ArticleIdList": ["10.1111/cas.12978", "PMC4982579", "27234159"]}, {"Citation": "Yu L., Fan Z., Fang S., Yang J., Gao T., Sim\u00f5es B.M., Eyre R., Guo W., Clarke R.B. Cisplatin selects for stem-like cells in osteosarcoma by activating notch signaling. Oncotarget. 2016;7:33055\u201333068. doi: 10.18632/oncotarget.8849.", "ArticleIdList": ["10.18632/oncotarget.8849", "PMC5078075", "27102300"]}, {"Citation": "Dai G., Deng S., Guo W., Yu L., Yang J., Zhou S., Gao T. Notch pathway inhibition using DAPT, a \u03b3-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma. Mol. Carcinog. 2019;58:3\u201318. doi: 10.1002/mc.22873.", "ArticleIdList": ["10.1002/mc.22873", "29964327"]}, {"Citation": "Vathipadiekal V., Saxena D., Mok S.C., Hauschka P.V., Ozbun L., Birrer M.J. Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer. PLoS ONE. 2012;7:e29079. doi: 10.1371/journal.pone.0029079.", "ArticleIdList": ["10.1371/journal.pone.0029079", "PMC3260150", "22272227"]}, {"Citation": "McAuliffe S.M., Morgan S.L., Wyant G.A., Tran L.T., Muto K.W., Chen Y.S., Chin K.T., Partridge J.C., Poole B.B., Cheng K.H., et al. Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy. Proc. Natl. Acad. Sci. USA. 2012;109:E2939\u2013E2948. doi: 10.1073/pnas.1206400109.", "ArticleIdList": ["10.1073/pnas.1206400109", "PMC3491453", "23019585"]}, {"Citation": "Jiang L.Y., Zhang X.L., Du P., Zheng J.H. \u03b3-Secretase inhibitor, DAPT inhibits self-renewal and stemness maintenance of ovarian cancer stem-like cells in vitro. Chin. J. Cancer Res. 2011;23:140\u2013146. doi: 10.1007/s11670-011-0140-1.", "ArticleIdList": ["10.1007/s11670-011-0140-1", "PMC3587542", "23482909"]}, {"Citation": "Li H., Zhang W., Niu C., Lin C., Wu X., Jian Y., Li Y., Ye L., Dai Y., Ouyang Y., et al. Nuclear orphan receptor NR2F6 confers cisplatin resistance in epithelial ovarian cancer cells by activating the Notch3 signaling pathway. Int. J. Cancer. 2019;145:1921\u20131934. doi: 10.1002/ijc.32293.", "ArticleIdList": ["10.1002/ijc.32293", "PMC6767785", "30895619"]}, {"Citation": "Kang M., Jiang B., Xu B., Lu W., Guo Q., Xie Q., Zhang B., Dong X., Chen D., Wu Y. Delta like ligand 4 induces impaired chemo-drug delivery and enhanced chemoresistance in pancreatic cancer. Cancer Lett. 2013;330:11\u201321. doi: 10.1016/j.canlet.2012.11.015.", "ArticleIdList": ["10.1016/j.canlet.2012.11.015", "23200678"]}, {"Citation": "Palagani V., El Khatib M., Kossatz U., Bozko P., M\u00fcller M.R., Manns M.P., Krech T., Malek N.P., Plentz R.R. Epithelial Mesenchymal Transition and Pancreatic Tumor Initiating CD44+/EpCAM+ Cells Are Inhibited by \u03b3-Secretase Inhibitor IX. PLoS ONE. 2012;7:e46514. doi: 10.1371/journal.pone.0046514.", "ArticleIdList": ["10.1371/journal.pone.0046514", "PMC3477166", "23094026"]}, {"Citation": "Harbuzariu A., Rampoldi A., Daley-Brown D.S., Candelaria P., Harmon T.L., Lipsey C.C., Beech D.J., Quarshie A., Ilies G.O., Gonzalez-Perez R.R. Leptin-Notch signaling axis is involved in pancreatic cancer progression. Oncotarget. 2017;8:7740\u20137752. doi: 10.18632/oncotarget.13946.", "ArticleIdList": ["10.18632/oncotarget.13946", "PMC5352357", "27999190"]}, {"Citation": "Capodanno Y., Buishand F.O., Pang L.Y., Kirpensteijn J., Mol J.A., Argyle D.J. Notch pathway inhibition targets chemoresistant insulinoma cancer stem cells. Endocr. Relat. Cancer. 2018;25:131\u2013144. doi: 10.1530/ERC-17-0415.", "ArticleIdList": ["10.1530/ERC-17-0415", "29175872"]}, {"Citation": "Lee J.Y., Song S.Y., Park J.Y. Notch pathway activation is associated with pancreatic cancer treatment failure. Pancreatology. 2014;14:48\u201353. doi: 10.1016/j.pan.2013.11.011.", "ArticleIdList": ["10.1016/j.pan.2013.11.011", "24555978"]}, {"Citation": "Bailey J.M., Alsina J., Rasheed Z.A., McAllister F.M., Fu Y.Y., Plentz R., Zhang H., Pasricha P.J., Bardeesy N., Matsui W., et al. DCLK1 marks a morphologically distinct subpopulation of cells with stem cell properties in preinvasive pancreatic cancer. Gastroenterology. 2014;146:245\u2013256. doi: 10.1053/j.gastro.2013.09.050.", "ArticleIdList": ["10.1053/j.gastro.2013.09.050", "PMC3910427", "24096005"]}, {"Citation": "Abel E.V., Kim E.J., Wu J., Hynes M., Bednar F., Proctor E., Wang L., Dziubinski M.L., Simeone D.M. The notch pathway is important in maintaining the cancer stem cell population in pancreatic cancer. PLoS ONE. 2014;9:e91983. doi: 10.1371/journal.pone.0091983.", "ArticleIdList": ["10.1371/journal.pone.0091983", "PMC3960140", "24647545"]}, {"Citation": "Mizuma M., Rasheed Z.A., Yabuuchi S., Omura N., Campbell N.R., De Wilde R.F., De Oliveira E., Zhang Q., Puig O., Matsui W., et al. The gamma secretase inhibitor MRK-003 attenuates pancreatic cancer growth in preclinical models. Mol. Cancer Ther. 2012;11:1999\u20132009. doi: 10.1158/1535-7163.MCT-12-0017.", "ArticleIdList": ["10.1158/1535-7163.MCT-12-0017", "PMC3438318", "22752426"]}, {"Citation": "Yabuuchi S., Pai S.G., Campbell N.R., De Wilde R.F., De Oliveira E., Korangath P., Streppel M.M., Rasheed Z.A., Hidalgo M., Maitra A., et al. Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer. Cancer Lett. 2013;335:41\u201351. doi: 10.1016/j.canlet.2013.01.054.", "ArticleIdList": ["10.1016/j.canlet.2013.01.054", "PMC3665739", "23402814"]}, {"Citation": "Wang L., Ning J., Wakimoto H., Wu S., Wu C.L., Humphrey M.R., Rabkin S.D., Martuza R.L. Oncolytic Herpes Simplex Virus and PI3K Inhibitor BKM120 Synergize to Promote Killing of Prostate Cancer Stem-like Cells. Mol. Ther.\u2014Oncolytics. 2019;13:58\u201366. doi: 10.1016/j.omto.2019.03.008.", "ArticleIdList": ["10.1016/j.omto.2019.03.008", "PMC6468160", "31016228"]}, {"Citation": "Carvalho F.L.F., Marchionni L., Gupta A., Kummangal B.A., Schaeffer E.M., Ross A.E., Berman D.M. HES6 promotes prostate cancer aggressiveness independently of Notch signalling. J. Cell. Mol. Med. 2015;19:1624\u20131636. doi: 10.1111/jcmm.12537.", "ArticleIdList": ["10.1111/jcmm.12537", "PMC4511360", "25864518"]}, {"Citation": "Cui D., Dai J., Keller J.M., Mizokami A., Xia S., Keller E.T. Notch pathway inhibition using PF-03084014, a \u03b3-secretase inhibitor (GSI), enhances the antitumor effect of docetaxel in prostate cancer. Clin. Cancer Res. 2015;21:4619\u20134629. doi: 10.1158/1078-0432.CCR-15-0242.", "ArticleIdList": ["10.1158/1078-0432.CCR-15-0242", "PMC4609279", "26202948"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "12", "Day": "30"}, {"Year": "2021", "Month": "2", "Day": "4"}, {"Year": "2021", "Month": "2", "Day": "9"}, {"Year": "2021", "Month": "3", "Day": "6", "Hour": "1", "Minute": "15"}, {"Year": "2021", "Month": "3", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "2", "Day": "12"}], "PublicationStatus": "epublish", "ArticleIdList": ["33673088", "PMC7917912", "10.3390/molecules26040972", "molecules26040972"]}}], "PubmedBookArticle": []}